| Note |
Selective, effective, specific. Specific dopamine antagonist. The low incidence of side-effects with Dolmatil may be explained by its highly specific action in blocking the D2 dopamine receptors, implicated in schizophrenia. No reported cases of tardive dyskinesia in 15,000 patients. In a post marketing study of 15,000 patients, there were no reported cases of tardive dyskinesia in a 3 year follow-up period. The highly effective oral neuroleptic. Dolmatil is an oral neuroleptic for the treatment of acute and chronic schizophrenia. As effective as chlorpromazine, trifluoperazine, and haloperidol, Dolmatil has a lower incidence of extrapyramidal and autonomic side-effects. Simple Dosage. The dosage is simple, starting with 400mg twice daily and increasing, if necessary, to a maximum of 1,200mg b.d. In lower doses 200-400mg b.d. there are alerting and antidepressant effects which are particularly suitable for withdrawn patients. Dolmatil The oral neuroleptic in a class of its own. |
